PATENT CLAIM ANALYSIS

Application Number: 15945887
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "134100"]

Abstract:
Disclosed are tumor necrosis factor receptor 1B (TNFR-1B) signaling targets and TNFR-1B mutants and their uses for treatment of diseases and disorders.

Claim (Index 10):
A method for treating a subject with a disease or disorder selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, juvenile idiopathic arthritis, inflammation, autoimmune disease, immune disorder, Crohn's disease, ulcerative colitis and inflammatory bowel disease, the method comprising administering to the subject the fusion protein of  claim 6  in an amount effective to alleviate a sign or symptom of the disease or disorder.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.13636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14003756', '14849963', '14122611', '14211604', '13761864']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6272120864963353
- 35 USC 102 Novelty (BERT): 0.5360894684222973
- Combined Prediction Score: 0.6180998246889315
- Mean Citation Score: 311.067136
- Max Citation Score: 355.4463
- Similarity Product: 265.18905956547263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test